What is it about?

This study explores a new way to deliver haloperidol—a medication used to treat psychosis—without pills or injections. Researchers created a soft, skin-friendly gel that contains a natural ingredient called limonene, found in citrus peels. Limonene helps the medicine pass through the skin more easily. The gel is made with safe, cosmetic-grade materials and can be applied like a patch. It slowly releases the drug into the body over time, which could help patients maintain steady medication levels and avoid frequent dosing. This method may improve comfort, reduce side effects, and make treatment easier for people who need long-term therapy.

Featured Image

Why is it important?

This study introduces a skin-friendly gel that uses limonene, a natural compound from citrus peels, to help deliver the antipsychotic drug haloperidol through the skin. What sets it apart is the use of a cosmetic-grade organogel—a soft, stable material that can be fine-tuned to control how quickly the drug is released. Unlike traditional pills or injections, this gel offers a non-invasive, long-acting alternative that could improve comfort and medication adherence for people with psychosis. It’s especially timely as healthcare systems seek gentler, more patient-friendly drug delivery methods, and as interest grows in natural enhancers like terpenes for medical applications. By showing how the gel’s structure affects drug release, this work lays the foundation for customizable transdermal therapies—not just for haloperidol, but potentially for other medications that benefit from slow, steady dosing.

Perspectives

What I find most compelling about this work is how elegantly it bridges pharmaceutical science with biomaterials engineering. The use of limonene—a naturally derived terpene—as a penetration enhancer isn’t just clever, it’s emblematic of a broader shift toward biocompatible, patient-friendly drug delivery systems. The gel’s tunable structure, dictated by GP1 concentration, offers a level of control that feels almost modular, like designing a circuit for drug release. From a systems-thinking angle, this study doesn’t just optimize one variable—it explores the interplay between gel rheology, drug diffusion, and skin permeability. That kind of multidimensional insight is rare and powerful. It opens the door to customizing transdermal therapies for a range of conditions, not just psychosis. And honestly, the fact that this formulation is thermoreversible and stable under moisture makes it feel like it’s not just scientifically sound—it’s practically ready for real-world application. It’s the kind of research that doesn’t just sit in a journal; it wants to be worn, used, and lived with.

Associate Prof. Lifeng Kang
University of Sydney

Read the Original

This page is a summary of: Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol, International Journal of Pharmaceutics, March 2006, Elsevier,
DOI: 10.1016/j.ijpharm.2005.12.042.
You can read the full text:

Read

Contributors

The following have contributed to this page